Literature DB >> 15804517

Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.

Pang-Chui Shaw1, Ka-Ming Lee, Kam-Bo Wong.   

Abstract

Trichosanthin (TCS), a ribosome-inactivating protein extracted from the root tuber of Chinese medicinal herb Trichosanthes kirilowii Maximowicz, has multiple pharmacological properties including abortifacient, anti-tumor and anti-HIV. It is traditionally used to induce abortion but its antigenicity and short plasma half-life have limited the repeated clinical administration. In this review, work to locating antigenic sites and prolonging plasma half-life are discussed. Studies on structure-function relationship and mechanism of cell entry are also covered. Recently, TCS has been found to induce apoptosis, enhance the action of chemokines and inhibit HIV-1 integrase. These findings give new insights on the pharmacological properties of TCS and other members of ribosome-inactivating proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804517     DOI: 10.1016/j.toxicon.2004.12.024

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  21 in total

1.  Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells.

Authors:  Jun Xu; De-Fu Gao; Guo-Li Yan; Jian-Ming Fan
Journal:  Mol Biol Rep       Date:  2008-09-05       Impact factor: 2.316

2.  Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.

Authors:  Yuchan Cai; Shudao Xiong; Yijie Zheng; Feifei Luo; Pei Jiang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2011-05-16       Impact factor: 11.530

3.  Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells.

Authors:  Hongbo Mo; Dongyun Ouyang; Lihui Xu; Qi Gao; Xianhui He
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

4.  Molecular cloning and characterization of an alpha-amylase inhibitor (TkAAI) gene from Trichosanthes kirilowii Maxim.

Authors:  Yipeng Zhang; Keyue Wang; Qiyuan Huang; Shaohua Shu
Journal:  Biotechnol Lett       Date:  2022-08-04       Impact factor: 2.716

5.  A switch-on mechanism to activate maize ribosome-inactivating protein for targeting HIV-infected cells.

Authors:  Sue Ka-Yee Law; Rui-Rui Wang; Amanda Nga-Sze Mak; Kam-Bo Wong; Yong-Tang Zheng; Pang-Chui Shaw
Journal:  Nucleic Acids Res       Date:  2010-06-17       Impact factor: 16.971

6.  Mechanism of the specific neuronal toxicity of a type I ribosome-inactivating protein, trichosanthin.

Authors:  Ou Sha; David Tai-Wai Yew; Eric Yu-Pang Cho; Tzi-Bun Ng; Lin Yuan; Wing-Hang Kwong
Journal:  Neurotox Res       Date:  2009-10-23       Impact factor: 3.911

7.  AtIQM1, a novel calmodulin-binding protein, is involved in stomatal movement in Arabidopsis.

Authors:  Yu-Ping Zhou; Jun Duan; Takahiro Fujibe; Kotaro T Yamamoto; Chang-En Tian
Journal:  Plant Mol Biol       Date:  2012-05-10       Impact factor: 4.076

8.  The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome.

Authors:  Priscilla Hiu-Mei Too; Meiji Kit-Wan Ma; Amanda Nga-Sze Mak; Yuen-Ting Wong; Christine Kit-Ching Tung; Guang Zhu; Shannon Wing-Ngor Au; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Nucleic Acids Res       Date:  2008-12-10       Impact factor: 16.971

Review 9.  Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.

Authors:  Ou Sha; Junfei Niu; Tzi-Bun Ng; Eric Yu-Pang Cho; Xiaoyuan Fu; Wenqi Jiang
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

10.  Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis.

Authors:  Evandro Fei Fang; Chris Zhi Yi Zhang; Lin Zhang; Jack Ho Wong; Yau Sang Chan; Wen Liang Pan; Xiu Li Dan; Cui Ming Yin; Chi Hin Cho; Tzi Bun Ng
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.